Keywords
ACE
molecular docking
Zygophyllum sp
myristic acid
linoleic acid
Abstract
Hypertension, a major contributor to global mortality, requires comprehensive management including lifestyle changes and medication. This study explores the potential of natural compounds from Zygophyllum sp as Angiotensin-converting enzyme (ACE) inhibitors, a key class of antihypertensive drugs. Using molecular docking methodology, we investigated the inhibitory effects of these compounds on the ACE enzyme (PDB: 1UZF). Our work demonstrated that several molecules exhibited promising binding scores compared to established reference ligands, suggesting potential ACE-inhibiting properties. Myristic acid showed the most favorable score (-9.2454 kcal/mol), surpassing conventional reference drugs. Geranyllinalool, Pseudophytol, Methyl linoleate and Phytol also demonstrated superior scores. 1-Octadecene and linoleic acid outperformed captopril and aligned closely with other reference ligand scores. The computational scores, largely exceeding those of established drugs, indicate strong affinities between Zygophyllum sp’s chemical constituents and the ACE enzyme. This suggests potential antihypertensive properties of the plant and its bioactive components, supporting its traditional use as an antihypertensive remedy. The notable efficacy scores of select known therapeutic agents further validate this potential. However, additional in-vitro and in-vivo investigations are necessary to robustly establish the ACE-inhibitory capability of Zygophyllum sp compounds. This study provides a foundation for further research into natural antihypertensive treatments, potentially offering new avenues for managing this widespread health concern.
References
1. WHO; 2023. [https://www.who.int/news-room/fact-sheets/detail/hypertension]
2. Kitt J, Fox R, Tucker KL, McManus RJ. New approaches in hypertension management: a Review of current and developing technologies and their potential impact on hypertension care. Curr Hypertens Rep. 2019;21(6):44.
3. Ott C, Schmieder RE. Diagnosis and treatment of arterial hypertension 2021. Kidney Int. 2022;101(1):36-46.
4. Khalil H, Zeltser R. Antihypertensive medications. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. [http://www.ncbi.nlm.nih.gov/books/NBK554579/]
5. Tedla YG, Bautista LE. Drug side effect symptoms and adherence to antihypertensive medication. Am J Hypertens. 2016;29(6):772-9.
6. Verma T, Sinha M, Bansal N, Yadav SR, Shah K, Chauhan NS. Plants used as antihypertensive. Nat Prod Bioprospect. 2021;11(2):155-84.
7. Bhuyan BJ, Mugesh G. Angiotensin converting enzyme inhibitors in the treatment of hypertension. Curr Sci. 2011;101(7):881-7.
8. Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation. 1998;97(14):1411-20.
9. Hilleman DE. Role of angiotensin-converting-enzyme inhibitors in the treatment of hypertension. Am J Health-Syst Pharm. 2000;1 (57 suppl_1):S8-11.
10. Cui W, Aouidate A, Wang S, Yu Q, Li Y, Yuan S. Discovering anti-cancer drugs via computational methods. Front Pharmacol. 2020;11:733.
11. Cox PB, Gupta R. Contemporary computational applications and tools in drug discovery. ACS Med Chem Lett. 2022;13(7):1016-29.
12. Zhang Y, Luo M, Wu P, Wu S, Lee TY, Bai C. Application of computational biology and artificial intelligence in drug design. Int J Mol Sci. 2022;23(21):13568.
13. Min KA, Zhang X, Yu J yu, Rosania GR. Computational approaches to analyse and predict small molecule transport and distribution at cellular and subcellular levels. Biopharm Drug Dispos. 2014;35(1):15-32.
14. Yosri M, Elaasser MM, Abdel-Aziz MM, Hassan MM, Alqhtani AH, Al-Gabri N, et al. Determination of therapeutic and safety effects of Zygophyllum coccineum extract in induced inflammation in rats. BioMed Res Int. 2022;18:1-17.
15. Mohammedi Z. Phytochemical, antidiabetic and therapeutic properties of Zygophyllum. Herb Med J. 2021;5(4):163-77.
16. Rachid A, Rabah D, Farid L, Zohra SF, Houcine B, Nacéra B. Ethnopharmacological survey of medicinal plants used in the traditional treatment of diabetes mellitus in the North Western and South Western Algeria. J Med Plants Res. 2012;6(10):97-103.
17. Zygophyllum L. WFO; 2023. [http://worldfloraonline.org/taxon/wfo-4000041345].
18. Akhgar MR, Rajaei P, Poshteshirani F. Composition of the essential oil of Zygophyllum eurypterum from Iran. Chem Nat Compd. 2015;51(3):577-8.
19. Kchaou M, Salah HB, Mnafgui K, Abdennabi R, Gharsallah N, Elfeki A, et al. Chemical composition and biological activities of Zygophyllum album (L.) Essential oil from Tunisia. J Agr Sci Tech. 2016;18:1499-510.
20. Mnafgui K, Kchaou M, Ben Salah H, Hajji R, Khabbabi G, Elfeki A,
et al. Essential oil of Zygophyllum album inhibits key-digestive enzymes related to diabetes and hypertension and attenuates symptoms of diarrhea in alloxan-induced diabetic rats. Pharm Biol. 2016;54(8):1326-33.
21. Mostafavi H, Vahiddost M, Solimanzadeh R. Chemical composition of essential oil of Zygophyllum fabago L. from North-West Iran. Int J Herb Med. 2015;2(6): 34-37.
22. Tigrinekordjani N, Meklati B, Chemat F. Analysis by gas chromatography–mass spectrometry of the essential oil of Zygophyllum album L., an aromatic and medicinal plant growing in Algeria. Int J Aromatherapy. 2006;16(3-4):187-91.
23. PubChem. [https://pubchem.ncbi.nlm.nih.gov/]
24. ChemSpider. [http://www.chemspider.com/]
25. Chemical, Computing Group Inc. Molecular Operating Environment (MOE). 1010 Sherbooke St. West, Suite #910. Montreal, QC, Canada. H3A 2R7; 2014.
26. Bernstein KE, Giani JF, Shen XZ, Gonzalez-Villalobos RA. Renal angiotensin-converting enzyme and blood pressure control. Curr Opin Nephrol Hypertens. 2014;23(2):106-12.
27. Herman LL, Padala SA, Ahmed I, et al. Angiotensin-Converting Enzyme Inhibitors (ACEI). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. [https://www.ncbi.nlm.nih.gov/books/NBK431051/].
28. Ibrahim SL, Jiroutek MR, Holland MA, Sutton BS. Utilization of angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in patients diagnosed with diabetes: Analysis from the National Ambulatory Medical Care Survey. Prev Med Rep. 2016;3:166-70.
29. Khurana V, Goswami B. Angiotensin converting enzyme (ACE). Clin Chim Acta. 2022;524:113-22.
30. RCSB Protein Data. [https://www.rcsb.org/search]
31. Natesh R, Schwager SLU, Sturrock ED, Acharya KR. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature. 2003;421(6922):551-4.
32. Soga S, Shirai H, Kobori M, Hirayama N. Use of amino acid composition to predict ligand-binding sites. J Chem Inf Model. 2007; 47(2):400-6.
33. Zheng L, Meng J, Jiang K, Lan H, Wang Z, Lin M, et al. Improving protein–ligand docking and screening accuracies by incorporating a scoring function correction term. Brief Bioinform. 2022;23(3):1-15.
34. Grinter S, Zou X. Challenges, Applications, and recent advances of protein-ligand docking in structure-based drug design. Molecules. 2014;19(7):10150-76.
35. Li J, Fu A, Zhang L. An overview of scoring functions used for protein–ligand interactions in molecular docking. Interdiscip Sci Comput Life Sci. 2019;11(2):320-8.
36. Pagadala NS, Syed K, Tuszynski J. Software for molecular docking: a review. Biophys Rev. 2017;9(2):91-102.
37. Jain AN. Scoring functions for protein-ligand docking. Curr Protein Pept Sci. 2006;7(5):407-20.
38. Guedes IA, Pereira FSS, Dardenne LE. Empirical scoring functions for structure-based virtual screening: Applications, critical aspects, and challenges. Front Pharmacol. 2018;9:1089.
39. Pason LP, Sotriffer CA. Empirical scoring functions for affinity prediction of protein-ligand complexes. Mol Inform. 2016; 35(11-12):541-8.
40. Wang Z, Wang X, Kang Y, Zhong H, Shen C, Yao X, et al. Binding affinity and dissociation pathway predictions for a series of USP7 inhibitors with pyrimidinone scaffold by multiple computational methods. Phys Chem Chem Phys. 2020;22(10):5487-99.
41. Liu J, Wang R. Classification of current scoring functions J. Chem. Inf. Model. 2015;55(3):475-82
42. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615-23.
43. Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337-41.
44. Violeta I, Miroslav R, Biljana A, Aleksandra P. Lipinski’s rule of five, famous extensions and famous exceptions. Chem N. 2020;3(1):171-81.
45. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.
46. Arbi B, Bouchentouf S, EL-Shazly M. Investigation of the potential antidiabetic effect of Zygophyllum sp. by studying the interaction of its chemical compounds with Alpha-Amylase and DPP-4 enzymes using a molecular docking approach. CEI. 2023;19(2):100-8.
47. Ke C, Zhu X, Zhang Y, Shen Y. Metabolomic characterization of hypertension and dyslipidemia. Metabolomics. 2018;14(9):117.
48. Anjos PJC, Lima AO, Cunha PS, De Sousa DP, Onofre ASC, Ribeiro TP, et al. Cardiovascular effects induced by linalool in normotensive and hypertensive rats. Z Naturforsch C J Biosci. 2013;68(5-6):181-90.
49. Camargo SB, Simões LO, Medeiros CFDA, De Melo Jesus A, Fregoneze JB, Evangelista A, et al. Antihypertensive potential of linalool and linalool complexed with β-cyclodextrin: Effects of subchronic treatment on blood pressure and vascular reactivity. Biochem Pharmacol. 2018;151:38-46.
50. Olofsson P, Hultqvist M, Hellgren LI, Holmdahl R. Phytol: A chlorophyll component with anti-inflammatory and metabolic properties. In: Jacob C, Kirsch G, Slusarenko A, Winyard PG, Burkholz T (eds). Recent advances in redox active plant and microbial products. Netherlands: Springer; 2014:345-59.
51. Mercola J, D’Adamo CR. Linoleic Acid: A narrative review of the effects of increased intake in the standard American diet and associations with chronic disease. Nutrients. 2023;15(14):3129.
52. Miura K, Stamler J, Nakagawa H, Elliott P, Ueshima H, Chan Q, et al. Relationship of dietary linoleic acid to blood pressure: The international study of macro-micronutrients and blood pressure study. Hypertension. 2008;52(2):408-14.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2024 Authors